RFK Jr. says the COVID-19 vaccine is no longer on the CDC's recommended schedule for healthy kids and pregnant women, though ...

Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...

HHS Secretary Robert F. Kennedy Jr. says the CDC no longer recommends COVID-19 vaccines for healthy pregnant women & children ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Last week saw Novavax receive full approval from the US Food and Drug Administration (FDA) for its COVID-19 vaccine, but with ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future of vaccine development in the U.S. faces growing challenges, including ...

The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have ...

Kepler Capital analyst Richard Withagen maintained a Buy rating on Diageo (DGEAF – Research Report) on May 23 and set a price target of p2,700.00. The company’s shares closed ...

France has detected four cases of the new COVID-19 variant NB.1.8.1 for the first time, Anadolu Ajansi reported. Four cases ...

Mergers and acquisitions grabbed the spotlight in the biotech sector once again this week after BioMarin BMRN agreed to acquire Inozyme Pharma INZY. Meanwhile, other pipeline and ...

The FDA had given Pfizer and Moderna until May 17 to propose changes to the labels of their COVID-19 vaccines or challenge ...

“If the FDA does not approve a vaccine for a population, then the vaccine will likely not be covered by insurers for that ...